Details of the Drug

General Information of Drug (ID: DM4MNY8)

Drug Name

DLYE-5953A

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT02092792) A Study Evaluating the Safety of Escalating Doses of DLYE5953A in Patients With Refractory Solid Tumors. U.S. National Institutes of Health.